ℹ️
🇬🇧
Search
Search for people relevant for "q(2)"
q(2)
Person
Class
Person
Publication
Programmes
Export current view
RNDr. Petr Grossmann Ph.D.
External person at Faculty of Medicine in Pilsen
53 publications
Publications
publication
Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture
2020 |
Faculty of Medicine in Pilsen
publication
Secretory carcinoma of the breast: A case report
2019 |
Faculty of Medicine in Pilsen
publication
Secretory Carcinoma of the Skin: Report of 6 Cases, Including a Case With a Novel NFIX-PKN1 Translocation
2019 |
Faculty of Medicine in Pilsen
publication
Small subset of adenoid cystic carcinoma of the skin is associated with alterations of the MYBL1 gene similar to their extracutaneous counterparts
2018 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Papillary renal cell carcinoma with cytologic ad molecular genetic features overlapping with renal oncocytoma: analysis of 10 cases
2018 |
Faculty of Medicine in Pilsen
publication
ALK Gene Fusions in Epithelioid Fibrous Histiocytoma: A Study of 14 Cases, With New Histopathological Findings
2018 |
Faculty of Medicine in Pilsen
publication
Molecular genetic alterations in renal cell carcinomas with tubulocystic pattern: tubulocystic renal cell carcinoma, tubulocystic renal cell carcinoma with heterogenous component and familial leiomyomatosis-associated renal cell carcinoma. Clinicopathologic and molecular genetic analysis of 15 cases
2016 |
Faculty of Medicine in Pilsen
publication
Chromophobe renal cell carcinoma with neuroendocrine and neuroendocrine-like features. Morphologic, immunohistochemical, ultrastructural, and array comparative genomic hybridization analysis of 18 cases and review of the literature
2015 |
Faculty of Medicine in Pilsen
publication
Distinctive renal cell tumor simulating atrophic kidney with 2 types of microcalcifications. Report of 3 cases
2014 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Molecular testing of HER2/neu of patients with breast cancer as a criterium for selection of Herceptin therapy- is our approach optimal?
2014 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
Load more publications (43)
Loading network view...